Structure |
Chemical Name |
CAS |
MF |
|
Verteporfin impurity |
121310-58-5 |
C40H40N4O8 |
|
Peramivir Impurity 25 |
|
|
|
Rocuronium Bromide Impurity 10 |
|
|
|
Peramivir Impurity 33 |
2758048-78-9 |
C18H34N2O5 |
|
Rocuronium Bromide Impurity 23 |
|
C23H39NO3 |
|
Imatinib impurity XT |
|
|
|
Cefoxitin EP Impurity G |
|
|
|
IOHEXOL RELATED COMPOUND C (100 MG) (N,N'- BIS(2,3-DIHYDROXYPROPYL)-5-NITRO-1,3-BENZENEDI- CARBOXAMIDE) |
|
|
|
Dextrorotation lansoprazole Impurity L |
|
|
|
lansoprazole Impurity 25 |
|
|
|
ファモチジン関連化合物B (3,5-BIS[2-[[[2-[(DIAMINOMETHYLENE)AMINO]THIAZOL-4-YL]METHYL]SULPHANY]ETHYL]-4H-1,2,4,6-THIATRIAZINE1,1-DIOXIDE) (AS) |
89268-62-2 |
C16H23N11O2S5 |
|
34-Methylcyanocobalamin |
38218-51-8 |
C64H90CoN14O14P |
|
Mirabegron Enantiomer Impurity |
|
|
|
Empagliflozin Impurity D |
|
|
|
Ipragliflozin Impurity 2 |
|
|
|
Nicergoline EP impurity F |
|
|
|
Mirabegron Impurity 4 |
|
|
|
TIZOXANIDE GLUCURONIDE, SODIUM SALT |
221287-83-8 |
C16H14N3NaO10S |
|
Bisoprolol EP Impurity D |
1225195-71-0 |
C26H40N2O5 |
|
2-(4-イソブトキシフェニル)-4-メチルチアゾール-5-カルボン酸 |
1206550-99-3 |
C15H17NO3S |
|
(5S,8R,9S,10S,13S,14S)-10,13-dimethyl-1,5,6,7,8,9,10,11,12,13,15,16-dodecahydro-4H-cyclopenta[a]phenanthren-17(14H)-one |
14639-79-3 |
C19H28O |
|
Cefuroxime Sodium Impurity |
|
C16H16N4NaO8S |
|
2-Bromo (S)-Carbidopa |
43197-33-7 |
C10H13BrN2O4 |
|
Eliglustat intermediate 3 |
491833-26-2 |
C23H28N2O5 |
|
Aztreonam Impurity B |
102586-36-7 |
C13H19N5O6S |
|
Olopatadine impurity |
|
|
|
Voriconazole Impurity 8 |
239807-03-5 |
C16H14F3N5O |
|
Caspofungin impurity 3 |
|
|
|
Plerixafor Impurity D |
|
|
|
Cefuroxime impurity 1 |
|
C16H16N4O8S |
|
Vonoprazan Impurity 9 |
|
|
|
Sitagliptin IMpurity 5 |
|
|
|
Brexpiprazole Impurity3 |
|
|
|
Levetiracetam impurity 5 |
1543300-90-8 |
C9H17NO4 |
|
Febuxostat Impurity B |
|
|
|
Sorafenib Impurity F |
|
|
|
Trelagliptin Impurity 1 |
1821400-07-0 |
C21H13ClF2N4O2 |
|
Vortioxetine Imp.J |
2137588-68-0 |
C18H22N2S |
|
4-amino-N-(1-(3-methoxypropyl)piperidin-4-yl)-2,3-dihydrobenzofuran-7-carboxamide |
1608459-56-8 |
C18H27N3O3 |
|
4,5-dichloro Rivaroxaban |
2305917-61-5 |
C25H28ClN3O6S |
|
Solifenacin EP Impurity B |
1534326-81-2 |
C31H28N2O |
|
Vildagliptin Impurity 6 |
1846606-31-2 |
C17H23N3O2 |
|
Sugammadex sodium Impurity 50 |
|
|
|
Cabozantinib impurity 39 |
|
|
|
Cabozantinib impurity 53 |
|
|
|
1-(2-chloro-2-(2,4-difluorophenyl)ethyl)-1H-1,2,4-triazole |
206050-24-0 |
C10H8ClF2N3 |
|
methyl 1-phenylethanesulfonate |
883835-57-2 |
C9H12O3S |
|
Doxofylline Impurity 22 |
|
|
|
Dapoxetine impurity 61 |
|
|
|
Ropivacaine Impurity 44 |
|
|
|
Ropivacaine Impurity 7 |
|
|
|
Sugammadex sodium Org199010-1 Impurity |
|
|
|
Sugammadex sodium Org226100-1 Impurity |
|
|
|
Butyphthalide impurity 26 |
|
|
|
Flucloxacillin Impurity A |
|
|
|
Nicorandil Impurity 1 |
|
|
|
Piperacillin Impurity 6 |
|
|
|
Bosutinib Impurity 5 |
1391063-17-4 |
C26H29Cl2N5O3 |
|
Levomilnacipran impurity |
|
|
|
Sofosbuvir IMpurity 4 |
|
|
|
1,3-bis(4-isobutylphenyl)butan-1-one |
|
C24H32O |
|
6-isobutyl-3-methyl-2,3-dihydro-1H-inden-1-one |
1340024-54-5 |
C14H18O |
|
2-(2-ピリジニルアミノ)グリオキシル酸エチル |
41374-72-5 |
C9H10N2O3 |
|
Canagliflozin Impurity 18 |
|
|
|
Canagliflozin Impurity 23 |
|
|
|
Carfilzomib Impurity 4 |
|
|
|
Lenvatinib Impurity 2 |
2380197-90-8 |
C28H22ClN5O5 |
|
FeBuxostat Impurity 33 |
100118-38-5 |
C12H14O5 |
|
(S)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl) |
1642630-12-3 |
C22H22N6O |
|
Latamoxef Impurity 1 |
75007-70-4 |
C19H20N6O7S |
|
Amlodipine iMpurity K |
1809326-44-0 |
C18H21ClN2O5 |
|
Cabozantinib impurity 4 |
95932-39-1 |
C11H15NO3 |
|
Rosuvastatin EP Impurity C |
1620823-61-1 |
C22H27FN3NaO6S |
|
4-(フェニルアミノ)-6,7-ビス(2-メトキシエトキシ)キナゾリン |
1145671-52-8 |
C20H23N3O4 |
|
(3R,4R,5S)-ethyl 4-acetamido-5-amino-3-isopropoxycyclohex-1-enecarboxylate |
1052063-36-1 |
C14H24N2O4 |
|
4-(N-(tert-butyl)acetamido)-5-(diallylamino)-3-(pentan-3-yloxy)cyclohex-1-enecarboxylate |
941296-96-4 |
C16H28N2O4 |
|
(2R,5S)-5-(4-amino-5-fluoro-2-oxopyrimidin-1(2H)-yl)-1,3-oxathiolane-2-carboxylic acid |
|
C8H8FN3O4S |
|
Amlodipine Impurity 10 |
2170104-51-3 |
C26H31ClN2O8S |
|
Clopidogrel Impurity 8 |
|
C15H14ClNO2S |
|
Nilotinib genotoxic impurity 3 |
915711-42-1 |
C19H17F3N4O |
|
Dapagliflozin Open Ring |
2100872-88-4 |
C21H27ClO7 |
|
Rortezide impurity |
|
|
|
Cabozantinib Impurity A |
|
|
|
Loxoprofen Impurity E |
|
|
|
(R)-4-Propylpyrrolidin-2-one |
930123-37-8 |
C7H13NO |
|
Rocuronium Bromide Intermediate B Impurity E-1 |
1190105-60-2 |
C29H48N2O3 |
|
Dapoxetine impurity 55 |
|
|
|
1-METHYLBIGUANIDE SULPHATE |
1609-00-3 |
C3H9N5 |
|
1-(3,5-DIHYDROXYPHENYL)-2-[(1,1-DIMETHYLETHYL)AMINO]-ETHANONE, HYDROCHLORIDE |
1246815-70-2 |
C12H18ClNO3 |
|
4-(((2R,3S,4R,5R,6R)-6-(Benzyloxy)-3-((diphenoxyphosphoryl)oxy)-4-(tetradecanoyloxy)-5-((S)-3-(tetradecanoyloxy)tetradecanaMido)tetrahydro-2H-pyran-2-yl)Methoxy)-4-oxobutanoic acid |
110611-91-1 |
C71H110NO15P |
|
Oxacillin Impurity H |
|
|
|
(2S,3R)-3-(6-(1-(6-chloro-5-fluoropyrimidin-4-yl)ethyl)-5-fluoropyrimidin-4-yl)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol |
|
|
|
PeraMpanel |
380918-54-7 |
C23H15N3O |
|
Butyphthalide impurity 32 |
|
|
|
Canagliflozin Impurity 30 |
|
|
|
Celecoxib Impurity 20 |
343853-74-7 |
C6H7N3O3S |
|
Emtricitabine Impurity CFTU1 |
|
|
|
Febuxostat Impurity 82 |
|
|
|
Febuxostat Impurity 87 |
|
|
|
Gefitinib Impurity R |
|
|